Geeta S. Vemuri

  • Partner, Quaker BioVenture, Philadelphia, US

    Dr. Geeta S. Vemuri is a Partner at Quaker BioVentures. Dr. Vemuri has been a Partner with the firm since 2008. She joined the firm as a Senior Associate in 2003 and was promoted to a Vice President in 2005. Previously, Dr. Vemuri was an Associate at Toucan Capital Corp., where she was responsible for investments in seed-stage and start-up biotech opportunities. At Toucan, Dr. Vemuri participated in raising the capital for Toucan Fund II from the states of Maryland and West Virginia and the Small Business Administration (SBA). Dr. Vemuri also helped start several portfolio companies by identifying and sourcing technologies from universities in the Mid-Atlantic region. Prior to joining Toucan, she was an Associate Equity Analyst at SalomonSmithBarney and First Union Securities, where Dr. Vemuri helped those firms cover the specialty pharmaceuticals and healthcare sectors. She currently serves on the Board of Corridor Pharma, Cempra Pharmaceuticals, Immune Control, NuPathe, Arginetix, Inc., and StageMark. She is a Board Observer at Optherion, Immune Control, Protez Pharmaceuticals, Regado Biosciences, Tengion, and Tranzyme Pharma. Dr. Vemuri joined Board of Directors of Argolyn Bioscience, Inc. on June 25, 2007. She served on the Boards of Cellatope and Protez Pharmaceuticals. She is also on the Board of Directors and Executive Committee of Southeast BIO, the Advisory Committee of BioAdvance – the Biotechnology Greenhouse of Southeastern Pennsylvania, and the Selection Committee for the “Best Incubator Company of the Year” awards for companies located in Maryland. Dr. Vemuri is on the Advisory Board of Fox Chase Cancer Center’s Innovation Fund and the Sid Martin Biotechnology Incubator. Dr. Vemuri has been very active in the Mid-Atlantic region’s biotechnology community. Dr. Vemuri is a regularly invited speaker at the Wharton Healthcare Program. Prior to her career in business, Dr. Vemuri worked as a Research Scientist at The Wistar Institute and as a postdoctoral fellow at Thomas Jefferson University. Dr. Vemuri holds a Ph.D. in Biochemistry from Indian Institute of Sciences, an M.B.A. from the Wharton School of the University of Pennsylvania, and a M.S. from Central University, India.

  • Conference Info:

     

    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City


    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!